IGF2BP3 and leukemia: Overall, a direct interaction between IGF2BP3 and IGF2, with a consequent promotion of cell proliferation in vitro, has been demonstrated in leukemia (Liao et al., 2005), thyroid cancer (Panebianco et al., 2017), and glioma (Suvasini et al., 2011).